1. P375 Inflammatory cutaneous lesions in inflammatory bowel disease treated with vedolizumab or ustekinumab: an ECCO CONFER multi-centre case series. (25th January 2019) Authors: Phillips, F M; Verstockt, B; Sebastian, S; Ribaldone, D G; Vavricka, S; Konstantinos, K; Slattery, E; de Suray, N; Flores, C; Fries, W; Vincenzi, F; Capoferro, E; Bachmann, O; Kopylov, U Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S292 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P472 Changes in colectomy for Ulcerative Colitis during the last two decades: an in-depth retrospective analysis. (21st January 2022) Authors: Le Cosquer, G; Capirchio, L; Rivière, P; de Suray, N; Poullenot, F; De Vroey, B; Berger, A; Denis, M A; Zerbib, F; Bachmann, R; Remue, C; Celerier, B; Leonard, D; Denost, Q; Kartheuser, A; Laharie, D; Dewit, O Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i444 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P694 Genetic predisposition and thiopurine-induced pancreatitis in inflammatory bowel disease patients. (25th January 2019) Authors: Burnet, G; de Suray, N; De Vroey, B; Hoang, P; Coche, J-C; Denis, M; Gala, J-L; Dewit, O Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S467 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗